RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
216 hedge funds and large institutions have $2.46B invested in Revance Therapeutics, Inc. in 2023 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 63 increasing their positions, 74 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 74
Holders
216
Holding in Top 10
2
Calls
$57.2M
Puts
$22.6M
Top Buyers
| 1 | +$62.7M | |
| 2 | +$61M | |
| 3 | +$30.7M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$19.2M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$18.3M |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$21.9M | |
| 3 | -$13.5M | |
| 4 |
Jennison Associates
New York
|
-$12.6M |
| 5 |
Millennium Management
New York
|
-$12.4M |